Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments

  • By

  • Carolina Schwedhelm

  • Leonie Kunk

  • Dorota Pawlowska-Phelan

  • Olaf Behmer

  • Anja Plenske

  • Jessica Herrath

  • Diamant Thaçi

  • Agnes Kisser

  • April 13, 2026

Share

  • 1

    The study estimated a 1-year administrative prevalence of atopic dermatitis (AD) in Germany at 2.4%, highest in children aged 0-4 years.

  • 2

    Indicators of insufficient disease control in AD patients included infections, prolonged topical treatment, and a high number of active flares.

  • 3

    Current systemic therapies for AD have limitations, particularly for long-term use and in patients aged ≤ 18 years.

  • 4

    The study utilized claims data from a representative sample of the German population to analyze AD treatment patterns.

  • 5

    There is a need for improved understanding of systemic therapy use and disease control in patients with atopic dermatitis.

Original Source(s)

Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments

  • by Carolina Schwedhelm, Leonie Kunk, Dorota Pawlowska-Phelan, Olaf Behmer, Anja Plenske, Jessica Herrath, Diamant Thaçi, Agnes Kisser

  • April 13, 2026

Related Content

Comments on Dermatologists’ TikTok Videos on Atopic Dermatitis: Content Analysis

Comparative Analysis of Efficacy and Safety Between Benvitimod and Halometasone in Individuals with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Open-Label Randomized Trial

Mental Health May Impact Dermatologic Quality of Life

Poorer dermatology-related quality of life was associated with greater mental health issues, while habitual probiotic intake showed no measurable relationship with these outcomes.